STING1 and cancer: Strikingly, intratumoral administration of cGAMP had no effect on the growth rate of TRAMP-C2 tumors that were deficient in STING (Fig. 5B and C) suggesting that activation of STING in TRAMP-C2 cells is critical for anti-cancer responses of cGAMP in this model.